We could not find any results for:
Make sure your spelling is correct or try broadening your search.
It is the gold standard of success in biotech, but not many Australian companies can boast it – approval from the United States Food & Drug Administration (FDA) of a medicine you have...
http://www.fool.com.au/2015/03/12/heres-why-pharmaxis-ltd-shares-are-soaring-today/
NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic Fibrosis Patients NICE Approves Pharmaxis' Bronchitol® As An Important New Treatment Option For Cystic...
Pharmaxis Receives Approval to Market Bronchitol in the EU PR Newswire ELTVILLE, Germany, April 27, 2012 ELTVILLE, Germany, April 27, 2012 /PRNewswire/ -- Pharmaceutical company Pharmaxis (ASX:...
Pharmaxis Announces ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit J-code J7665 mannitol administered through inhaler PR Newswire EXTON, Pa., Jan. 3, 2012 EXTON, Pa., Jan. 3...
Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial Challenge Test Kit ARIDOL is the Only Dry Powder Bronchial Challenge Test Approved for Use in the U.S. PR...
Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, October 26, 2011 SYDNEY, October 26, 2011 /PRNewswire/ -- Pharmaceutical company Pharmaxis...
Pharmaceutical company Pharmaxis (ASX: PXS) today announced the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of...
Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe PR Newswire SYDNEY, Oct. 24, 2011 SYDNEY, Oct. 24, 2011 /PRNewswire/ -- Pharmaceutical company Pharmaxis (ASX: PXS...
The Committee for Medicinal Products for Human Use, or CHMP, said Friday that it has adopted positive opinions recommending the granting of marketing authorizations for Trajenta-linagliptin, from...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | -0.007 | -20.5882352941 | 0.034 | 0.04 | 0.0265 | 147947 | 0.03167899 | DE |
156 | -0.093 | -77.5 | 0.12 | 0.14 | 0.0265 | 420799 | 0.07159811 | DE |
260 | -0.168 | -86.1538461538 | 0.195 | 0.285 | 0.0265 | 722219 | 0.09157309 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions